| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.923 | 0.003 | 0.923 | Vasodilator, coronary | 0.543 0.011 CID_146012 | ||
| 0.9 | 0.002 | 0.9 | Calcium channel blocker | 0.757 0.003 CID_146012 | ||
| 0.895 | 0.001 | 0.895 | Calcium antagonist | 0.529 0.002 CID_146012 | ||
| 0.844 | 0.001 | 0.844 | Calcium channel L-type blocker | 0.627 0.002 CID_146012 | ||
| 0.842 | 0.003 | 0.842 | Vasodilator, peripheral | 0.628 0.013 CID_146012 | ||
| 0.811 | 0.003 | 0.811 | Calcium channel (voltage-sensitive) blocker | 0.581 0.004 CID_146012 | ||
| 0.788 | 0.001 | 0.788 | Calcium channel activator | 0.631 0.002 CID_146012 | ||
| 0.723 | 0.002 | 0.723 | Calcium channel L-type activator | 0.723 0.002 CID_146012 | ||
| 0.707 | 0.004 | 0.707 | Vasodilator | 0.458 0.015 CID_146012 | ||
| 0.545 | 0.003 | 0.545 | TRPA1 agonist | 0.172 0.019 CID_146012 | ||
| 0.515 | 0.014 | 0.515 | Cardiotonic | 0.248 0.084 CID_146012 | ||
| 0.472 | 0.009 | 0.472 | Cyclic AMP phosphodiesterase inhibitor | 0.289 0.046 CID_146012 | ||
| 0.509 | 0.084 | 0.581 | DNA polymerase beta inhibitor | 0.581 0.063 CID_146012 | CID_146012 | |
| 0.447 | 0.099 | 0.528 | DNA directed DNA polymerase inhibitor | 0.528 0.074 CID_146012 | CID_146012 | |
| 0.35 | 0.004 | 0.35 | Neuropeptide Y1 antagonist | 0.278 0.006 CID_146012 | ||
| 0.339 | 0.005 | 0.339 | Adenylate kinase inhibitor | 0.169 0.021 CID_146012 | ||
| 0.392 | 0.065 | 0.392 | Transcription factor NF kappa B inhibitor | 0.295 0.097 CID_146012 | ||
| 0.336 | 0.028 | 0.336 | Platelet aggregation inhibitor | |||
| 0.412 | 0.109 | 0.5 | Alpha-glucosidase inhibitor | 0.5 0.08 CID_146012 | CID_146012 | |
| 0.405 | 0.107 | 0.424 | Transcription factor inhibitor | 0.424 0.1 CID_146012 | CID_146012 | |
| 0.321 | 0.029 | 0.387 | Anesthetic general | 0.387 0.018 CID_146012 | CID_146012 | |
| 0.363 | 0.08 | 0.363 | Calpain 2 inhibitor | 0.317 0.104 CID_146012 | ||
| 0.325 | 0.061 | 0.325 | Spasmolytic | |||
| 0.371 | 0.109 | 0.395 | Beta lactamase inhibitor | 0.395 0.101 CID_146012 | CID_146012 | |
| 0.357 | 0.096 | 0.366 | 15-Lipoxygenase inhibitor | 0.366 0.09 CID_146012 | CID_146012 | |
| 0.33 | 0.072 | 0.33 | Antithrombotic | |||
| 0.261 | 0.005 | 0.261 | CF transmembrane conductance regulator agonist | 0.153 0.071 CID_146012 | ||
| 0.333 | 0.084 | 0.333 | Thioredoxin glutathione reductase inhibitor | 0.327 0.087 CID_146012 | ||
| 0.318 | 0.08 | 0.371 | Cholesterol antagonist | 0.371 0.057 CID_146012 | CID_146012 | |
| 0.244 | 0.015 | 0.244 | Alpha 2b adrenoreceptor antagonist | 0.134 0.048 CID_146012 | ||
| 0.294 | 0.066 | 0.382 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.382 0.042 CID_146012 | CID_146012 | |
| 0.275 | 0.049 | 0.275 | 5 Hydroxytryptamine 1E antagonist | 0.188 0.145 CID_146012 | ||
| 0.215 | 0.004 | 0.215 | Potassium channel intermediate-conductance Ca-activated blocker | 0.131 0.005 CID_146012 | ||
| 0.243 | 0.032 | 0.243 | Diuretic | |||
| 0.207 | 0.004 | 0.207 | Aldosterone antagonist | |||
| 0.264 | 0.066 | 0.264 | Platelet antagonist | |||
| 0.235 | 0.039 | 0.235 | Lipocortins synthesis antagonist | 0.157 0.095 CID_146012 | ||
| 0.232 | 0.048 | 0.232 | P-glycoprotein inhibitor | 0.185 0.075 CID_146012 | ||
| 0.233 | 0.051 | 0.266 | Non-steroidal antiinflammatory agent | 0.266 0.037 CID_146012 | CID_146012 | |
| 0.203 | 0.027 | 0.265 | GABA C receptor rho-2 antagonist | 0.265 0.009 CID_146012 | CID_146012 | |
| 0.189 | 0.02 | 0.189 | Alpha 2c adrenoreceptor antagonist | 0.11 0.058 CID_146012 | ||
| 0.198 | 0.032 | 0.254 | Mannose-6-phosphate isomerase inhibitor | 0.254 0.011 CID_146012 | CID_146012 | |
| 0.256 | 0.095 | 0.256 | Hypoxia-inducible factor 1 alpha inhibitor | 0.245 0.105 CID_146012 | ||
| 0.262 | 0.102 | 0.375 | 12-Lipoxygenase inhibitor | 0.375 0.047 CID_146012 | CID_146012 | |
| 0.172 | 0.017 | 0.172 | Androgen antagonist | |||
| 0.307 | 0.172 | 0.38 | MAP kinase 1 inhibitor | 0.38 0.118 CID_146012 | CID_146012 | |
| 0.17 | 0.035 | 0.17 | Farnesoid X receptor antagonist | |||
| 0.224 | 0.09 | 0.532 | Aryl hydrocarbon receptor agonist | 0.532 0.021 CID_146012 | CID_146012 | |
| 0.212 | 0.084 | 0.214 | RNA-directed DNA polymerase inhibitor | 0.214 0.081 CID_146012 | CID_146012 | |
| 0.192 | 0.064 | 0.208 | Sigma receptor agonist | 0.208 0.059 CID_146012 | CID_146012 | |
| 0.31 | 0.183 | 0.487 | Caspase 9 stimulant | 0.487 0.065 CID_146012 | CID_146012 | |
| 0.141 | 0.016 | 0.141 | Alpha 1d adrenoreceptor antagonist | |||
| 0.204 | 0.078 | 0.204 | Psychostimulant | |||
| 0.147 | 0.023 | 0.156 | Toll-Like receptor 4 antagonist | 0.156 0.018 CID_146012 | CID_146012 | |
| 0.143 | 0.023 | 0.143 | Alpha 1b adrenoreceptor antagonist | |||
| 0.13 | 0.015 | 0.13 | Adenosine A3 receptor antagonist | 0.082 0.041 CID_146012 | ||
| 0.26 | 0.146 | 0.404 | GABA C receptor rho-3 antagonist | 0.404 0.06 CID_146012 | CID_146012 | |
| 0.119 | 0.006 | 0.119 | Mineralocorticoid receptor antagonist | |||
| 0.155 | 0.047 | 0.444 | Anesthetic local | 0.444 0.005 CID_146012 | CID_146012 | |
| 0.141 | 0.037 | 0.172 | Photosensitizer | 0.172 0.021 CID_146012 | CID_146012 | |
| 0.136 | 0.035 | 0.136 | Mediator release inhibitor | |||
| 0.112 | 0.012 | 0.112 | Beta adrenoreceptor antagonist | |||
| 0.144 | 0.048 | 0.144 | Platelet activating factor antagonist | |||
| 0.177 | 0.083 | 0.177 | Hepatoprotectant | |||
| 0.159 | 0.069 | 0.262 | Cytidine deaminase inhibitor | 0.262 0.026 CID_146012 | CID_146012 | |
| 0.17 | 0.081 | 0.17 | Amyloid beta precursor protein antagonist | 0.17 0.081 CID_146012 | ||
| 0.147 | 0.059 | 0.147 | Pregnane X receptor agonist | |||
| 0.191 | 0.105 | 0.191 | Nitric-oxide synthase stimulant | 0.188 0.11 CID_146012 | ||
| 0.111 | 0.029 | 0.111 | Bile acid receptor antagonist | |||
| 0.167 | 0.085 | 0.194 | Succinate dehydrogenase inhibitor | 0.194 0.054 CID_146012 | CID_146012 | |
| 0.113 | 0.033 | 0.113 | Neuropeptide Y antagonist | |||
| 0.223 | 0.143 | 0.367 | Thyroid hormone antagonist | 0.367 0.067 CID_146012 | CID_146012 | |
| 0.134 | 0.056 | 0.172 | Alkylator | 0.172 0.036 CID_146012 | CID_146012 | |
| 0.105 | 0.028 | 0.105 | Glycine receptor antagonist | |||
| 0.113 | 0.037 | 0.113 | Potassium channel activator | |||
| 0.131 | 0.055 | 0.132 | Sphingosine 1-phosphate receptor 4 antagonist | 0.132 0.054 CID_146012 | CID_146012 | |
| 0.204 | 0.128 | 0.204 | Transcription factor STAT3 inhibitor | |||
| 0.088 | 0.014 | 0.088 | Beta 1 adrenoreceptor antagonist | |||
| 0.104 | 0.03 | 0.13 | Granulocyte macrophage colony stimulating factor agonist | 0.13 0.011 CID_146012 | CID_146012 | |
| 0.237 | 0.165 | 0.364 | Histamine release inhibitor | 0.364 0.093 CID_146012 | CID_146012 | |
| 0.103 | 0.035 | 0.106 | Glutathione S-transferase inhibitor | 0.106 0.032 CID_146012 | CID_146012 | |
| 0.212 | 0.144 | 0.353 | Thyroid hormone beta antagonist | 0.353 0.068 CID_146012 | CID_146012 | |
| 0.079 | 0.012 | 0.079 | Thromboxane synthase inhibitor | 0.061 0.026 CID_146012 | ||
| 0.084 | 0.019 | 0.084 | Nitric oxide donor | 0.066 0.038 CID_146012 | ||
| 0.144 | 0.079 | 0.147 | NOS3 expression enhancer | 0.147 0.075 CID_146012 | CID_146012 | |
| 0.144 | 0.08 | 0.144 | Phospholipase A2 inhibitor | 0.119 0.118 CID_146012 | ||
| 0.139 | 0.078 | 0.14 | Heat shock protein 70 antagonist | 0.14 0.077 CID_146012 | CID_146012 | |
| 0.113 | 0.053 | 0.113 | Beta glucuronidase inhibitor | 0.104 0.063 CID_146012 | ||
| 0.068 | 0.01 | 0.068 | Glutamate (mGluR group III) antagonist | 0.055 0.016 CID_146012 | ||
| 0.1 | 0.041 | 0.13 | Interleukin 5 antagonist | 0.13 0.018 CID_146012 | CID_146012 | |
| 0.07 | 0.012 | 0.07 | Potassium channel (Inward rectifier) activator | |||
| 0.08 | 0.024 | 0.08 | Glutamate (mGluR6) antagonist | 0.072 0.036 CID_146012 | ||
| 0.067 | 0.011 | 0.067 | Potassium channel (ATP-sensitive) activator | |||
| 0.173 | 0.121 | 0.173 | Free radical scavenger | 0.153 0.142 CID_146012 | ||
| 0.206 | 0.153 | 0.353 | Prostaglandin dehydrogenase inhibitor | 0.353 0.081 CID_146012 | CID_146012 | |
| 0.106 | 0.055 | 0.122 | UDP-glucose 4-epimerase inhibitor | 0.122 0.042 CID_146012 | CID_146012 | |
| 0.069 | 0.018 | 0.069 | Nicotinic alpha3beta2 receptor antagonist | 0.062 0.024 CID_146012 | ||
| 0.213 | 0.164 | 0.213 | Apoptosis antagonist | |||
| 0.089 | 0.043 | 0.089 | Alpha 2a adrenoreceptor antagonist | |||
| 0.051 | 0.006 | 0.051 | Transforming growth factor beta 2 antagonist | |||
| 0.119 | 0.079 | 0.132 | M17 leucyl aminopeptidase inhibitor | 0.132 0.068 CID_146012 | CID_146012 | |
| 0.093 | 0.06 | 0.093 | Antiadrenergic | |||
| 0.077 | 0.045 | 0.111 | Histidine decarboxylase inhibitor | 0.111 0.028 CID_146012 | CID_146012 | |
| 0.052 | 0.019 | 0.052 | Glutamate (mGluR4) antagonist | 0.044 0.029 CID_146012 | ||
| 0.06 | 0.028 | 0.092 | Dihydroorotate dehydrogenase inhibitor | 0.092 0.014 CID_146012 | CID_146012 | |
| 0.078 | 0.046 | 0.078 | Histone deacetylase SIRT1 stimulant | |||
| 0.078 | 0.046 | 0.078 | Histone deacetylase stimulant | |||
| 0.091 | 0.06 | 0.091 | Adrenaline antagonist | |||
| 0.063 | 0.034 | 0.063 | Calcium channel T-type blocker | |||
| 0.191 | 0.163 | 0.191 | Gastrin inhibitor | |||
| 0.175 | 0.15 | 0.273 | Streptokinase A inhibitor | 0.273 0.091 CID_146012 | CID_146012 | |
| 0.047 | 0.023 | 0.082 | GABA B receptor antagonist | 0.082 0.006 CID_146012 | CID_146012 | |
| 0.09 | 0.065 | 0.218 | Breast cancer-resistant protein inhibitor | 0.218 0.012 CID_146012 | CID_146012 | |
| 0.061 | 0.038 | 0.078 | Glutamate (mGluR1) antagonist | 0.078 0.024 CID_146012 | CID_146012 | |
| 0.115 | 0.092 | 0.17 | Interleukin 4 antagonist | 0.17 0.035 CID_146012 | CID_146012 | |
| 0.072 | 0.049 | 0.072 | Alpha 1a adrenoreceptor antagonist | |||
| 0.167 | 0.145 | 0.167 | Antioxidant | |||
| 0.106 | 0.084 | 0.135 | M18 aspartyl aminopeptidase inhibitor | 0.135 0.06 CID_146012 | CID_146012 | |
| 0.075 | 0.054 | 0.075 | GABA B receptor agonist | 0.075 0.053 CID_146012 | ||
| 0.047 | 0.028 | 0.059 | Fructose-1,6-bisphosphatase inhibitor | 0.059 0.018 CID_146012 | CID_146012 | |
| 0.098 | 0.079 | 0.128 | DOPA decarboxylase inhibitor | 0.128 0.037 CID_146012 | CID_146012 | |
| 0.049 | 0.031 | 0.049 | Phosphorylase inhibitor | |||
| 0.04 | 0.022 | 0.04 | Progesterone antagonist | |||
| 0.134 | 0.117 | 0.143 | Interleukin 6 antagonist | 0.143 0.099 CID_146012 | CID_146012 | |
| 0.066 | 0.05 | 0.066 | MDM2 inhibitor | 0.066 0.049 CID_146012 | ||
| 0.085 | 0.071 | 0.086 | Thioredoxin inhibitor | 0.086 0.069 CID_146012 | CID_146012 | |
| 0.049 | 0.036 | 0.049 | Sodium/calcium exchanger inhibitor | 0.048 0.04 CID_146012 | ||
| 0.103 | 0.09 | 0.105 | Calcium channel N-type blocker | 0.105 0.086 CID_146012 | CID_146012 | |
| 0.044 | 0.031 | 0.044 | Dihydroorotase inhibitor | 0.04 0.038 CID_146012 | ||
| 0.062 | 0.05 | 0.062 | Phosphodiesterase III inhibitor | |||
| 0.059 | 0.048 | 0.065 | Transcription factor AP-1 inhibitor | 0.065 0.037 CID_146012 | CID_146012 | |
| 0.078 | 0.067 | 0.078 | Ca(v)2.2 blocker | |||
| 0.089 | 0.079 | 0.125 | GABA C receptor rho-1 antagonist | 0.125 0.036 CID_146012 | CID_146012 | |
| 0.1 | 0.09 | 0.1 | Microtubule formation inhibitor | |||
| 0.139 | 0.131 | 0.139 | Neurotensin receptor agonist | |||
| 0.077 | 0.069 | 0.094 | Thioredoxin reductase inhibitor | 0.094 0.035 CID_146012 | CID_146012 | |
| 0.084 | 0.077 | 0.084 | ABCA1 expression enhancer | |||
| 0.036 | 0.031 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 CID_146012 | CID_146012 | |
| 0.109 | 0.104 | 0.187 | Toll-Like receptor antagonist | 0.187 0.035 CID_146012 | CID_146012 | |
| 0.066 | 0.062 | 0.066 | Alpha 1 adrenoreceptor antagonist | |||
| 0.018 | 0.014 | 0.019 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.012 CID_146012 | CID_146012 | |
| 0.093 | 0.089 | 0.105 | GABA C receptor antagonist | 0.105 0.07 CID_146012 | CID_146012 | |
| 0.086 | 0.083 | 0.086 | Interleukin 12 antagonist | |||
| 0.084 | 0.081 | 0.099 | Phosphodiesterase 7B inhibitor | 0.099 0.057 CID_146012 | CID_146012 | |
| 0.075 | 0.073 | 0.086 | Ornithine decarboxylase inhibitor | 0.086 0.061 CID_146012 | CID_146012 | |
| 0.059 | 0.056 | 0.083 | Interferon inducer | 0.083 0.022 CID_146012 | CID_146012 | |
| 0.133 | 0.134 | 0.164 | 3C-like protease (Human coronavirus) inhibitor | 0.164 0.081 CID_146012 | CID_146012 | |
| 0.045 | 0.047 | 0.059 | CD45 antagonist | 0.059 0.022 CID_146012 | CID_146012 | |
| 0.121 | 0.124 | 0.172 | Mcl-1 antagonist | 0.172 0.072 CID_146012 | CID_146012 | |
| 0.028 | 0.035 | 0.033 | Purinergic P2Y2 antagonist | 0.033 0.024 CID_146012 | CID_146012 | |
| 0.082 | 0.089 | 0.132 | Xanthine oxidase inhibitor | 0.132 0.042 CID_146012 | CID_146012 | |
| 0.155 | 0.164 | 0.358 | DNA damaging | 0.358 0.039 CID_146012 | CID_146012 | |
| 0.067 | 0.078 | 0.097 | Interferon agonist | 0.097 0.032 CID_146012 | CID_146012 | |
| 0.135 | 0.146 | 0.155 | Catenin beta inhibitor | 0.155 0.095 CID_146012 | CID_146012 | |
| 0.044 | 0.055 | 0.069 | Alcohol oxidase inhibitor | 0.069 0.029 CID_146012 | CID_146012 | |
| 0.019 | 0.03 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.019 CID_146012 | CID_146012 | |
| 0.025 | 0.04 | 0.035 | Catechol O-methyltransferase inhibitor | 0.035 0.02 CID_146012 | CID_146012 | |
| 0.06 | 0.074 | 0.073 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.073 0.057 CID_146012 | CID_146012 | |
| 0.157 | 0.175 | 0.185 | Superoxide dismutase inhibitor | 0.185 0.134 CID_146012 | CID_146012 | |
| 0.02 | 0.037 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.023 CID_146012 | CID_146012 | |
| 0.094 | 0.116 | 0.117 | Toll-Like receptor 2 antagonist | 0.117 0.081 CID_146012 | CID_146012 | |
| 0.039 | 0.061 | 0.105 | GABA A receptor antagonist | 0.105 0.015 CID_146012 | CID_146012 | |
| 0.085 | 0.109 | 0.118 | Multidrug resistance-associated protein 1 inhibitor | 0.118 0.051 CID_146012 | CID_146012 | |
| 0.096 | 0.124 | 0.162 | Alkaline phosphatase inhibitor | 0.162 0.052 CID_146012 | CID_146012 | |
| 0.036 | 0.071 | 0.091 | GABA receptor antagonist | 0.091 0.018 CID_146012 | CID_146012 | |
| 0.087 | 0.124 | 0.12 | Aldehyde dehydrogenase inhibitor | 0.12 0.07 CID_146012 | CID_146012 | |
| 0.013 | 0.05 | 0.027 | Kynurenine 3 monooxygenase inhibitor | 0.027 0.018 CID_146012 | CID_146012 | |
| 0.054 | 0.096 | 0.079 | Calcium channel P-type blocker | 0.079 0.015 CID_146012 | CID_146012 | |
| 0.026 | 0.068 | 0.058 | Angiotensin AT1 receptor antagonist | 0.058 0.008 CID_146012 | CID_146012 | |
| 0.067 | 0.11 | 0.083 | Triose-phosphate isomerase inhibitor | 0.083 0.07 CID_146012 | CID_146012 | |
| 0.106 | 0.149 | 0.197 | Dual specificity phosphatase 3 inhibitor | 0.197 0.062 CID_146012 | CID_146012 | |
| 0.049 | 0.093 | 0.06 | Bcl-xL inhibitor | 0.06 0.041 CID_146012 | CID_146012 | |
| 0.03 | 0.075 | 0.043 | Carbonic anhydrase XIV inhibitor | 0.043 0.042 CID_146012 | CID_146012 | |
| 0.041 | 0.087 | 0.099 | Sphingosine 1-phosphate receptor 4 agonist | 0.099 0.025 CID_146012 | CID_146012 | |
| 0.109 | 0.162 | 0.168 | DNA methyltransferase I inhibitor | 0.168 0.088 CID_146012 | CID_146012 | |
| 0.021 | 0.075 | 0.048 | Angiotensin II receptor antagonist | 0.048 0.008 CID_146012 | CID_146012 | |
| 0.025 | 0.084 | 0.046 | Leukocyte elastase inhibitor | 0.046 0.027 CID_146012 | CID_146012 | |
| 0.051 | 0.121 | 0.087 | Potassium channel (Ca-activated) activator | 0.087 0.068 CID_146012 | CID_146012 | |
| 0.127 | 0.198 | 0.221 | Histone acetyltransferase inhibitor | 0.221 0.044 CID_146012 | CID_146012 | |
| 0.142 | 0.213 | 0.27 | Lipoxygenase inhibitor | 0.27 0.087 CID_146012 | CID_146012 | |
| 0.197 | 0.279 | 0.252 | Apoptosis agonist | 0.252 0.212 CID_146012 | CID_146012 | |
| 0.099 | 0.185 | 0.158 | Dual specificity phosphatase inhibitor | 0.158 0.085 CID_146012 | CID_146012 | |
| 0.062 | 0.151 | 0.102 | GABA receptor agonist | 0.102 0.075 CID_146012 | CID_146012 | |
| 0.04 | 0.135 | 0.068 | Bcl2 antagonist | 0.068 0.044 CID_146012 | CID_146012 | |
| 0.158 | 0.253 | 0.201 | Sodium/bile acid cotransporter inhibitor | 0.201 0.186 CID_146012 | CID_146012 | |
| 0.202 | 0.303 | 0.299 | 5 Hydroxytryptamine release inhibitor | 0.299 0.166 CID_146012 | CID_146012 | |
| 0.025 | 0.135 | 0.046 | Benzodiazepine antagonist | 0.046 0.037 CID_146012 | CID_146012 | |
| 0.009 | 0.121 | 0.031 | Retinoid X receptor agonist | 0.031 0.029 CID_146012 | CID_146012 | |
| 0.018 | 0.135 | 0.049 | Xanthine dehydrogenase inhibitor | 0.049 0.048 CID_146012 | CID_146012 | |
| 0.065 | 0.218 | 0.128 | Interleukin 1 antagonist | 0.128 0.078 CID_146012 | CID_146012 | |
| 0.057 | 0.244 | 0.111 | NADPH oxidase inhibitor | 0.111 0.095 CID_146012 | CID_146012 | |
| 0.073 | 0.266 | 0.189 | Platelet adhesion inhibitor | 0.189 0.077 CID_146012 | CID_146012 | |
| 0.053 | 0.251 | 0.13 | Cytokine production inhibitor | 0.13 0.079 CID_146012 | CID_146012 | |
| 0.052 | 0.268 | 0.117 | Antibacterial (Helicobacter pylori) | 0.117 0.086 CID_146012 | CID_146012 | |
| 0.029 | 0.249 | 0.123 | 5-Lipoxygenase inhibitor | 0.123 0.049 CID_146012 | CID_146012 | |
| 0.048 | 0.297 | 0.181 | Pyruvate kinase inhibitor | 0.181 0.092 CID_146012 | CID_146012 | |
| 0.024 | 0.282 | 0.065 | Glutamate (mGluR group I) antagonist | 0.065 0.055 CID_146012 | CID_146012 | |
| 0.03 | 0.29 | 0.105 | Glutamate receptor antagonist | 0.105 0.091 CID_146012 | CID_146012 | |
| 0.079 | 0.358 | 0.196 | Hypoglycemic | 0.196 0.116 CID_146012 | CID_146012 | |
| 0.021 | 0.321 | 0.072 | Glutamate (mGluR) antagonist | 0.072 0.058 CID_146012 | CID_146012 | |
| 0.029 | 0.335 | 0.075 | Viral attachment inhibitor | 0.075 0.063 CID_146012 | CID_146012 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |